Warmest congratulations to all authors of the GP-TCM J. Ethnopharmacol. Special Issue, which has now been published! This represents one of the most important milestones of the FP7 GP-TCM Project and we sincerely thank all authors, reviewers and editors (Guest Co-editors Dr. Qihe Xu and Prof. Rudolf Bauer; Editor-in-Chief Prof. Rob Verpoorte) for their hard work and excellent collaboration.
As these publications are supported by public funding from the European Commission (FP7 grant agreement No. 223154), which particularly emphasises the importance of using public funding for public good, the Consortium has made all the articles open access and thus freely available to everyone.
We hope that you will enjoy reading this landmark collection of TCM-related articles as much as we have the pleasure in meeting the challenges. Please feel free to share them with any interested parties. Thank you!
1. Good Practices: The basis for evidence-based medicines.
Verpoorte R.
J Ethnopharmacol. 2012; 140: 455-457
http://www.sciencedirect.com/science/article/pii/S0378874112001183
2. Traditional Chinese medicine research in the post-genomic era: Good practice, priorities, challenges and opportunities.
Uzuner H, Bauer R, Fan TP, Guo DA, Dias A, El-Nezami H, Efferth T, Williamson EM, Heinrich M, Robinson N, Hylands PJ, Hendry BM, Cheng YC, Xu Q.
J Ethnopharmacol. 2012; 140: 458-468
http://www.sciencedirect.com/science/article/pii/S0378874112001110
3. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
Chan K, Shaw D, Simmonds MS, Leon CJ, Xu Q, Lu A, Sutherland I, Ignatova S, Zhu YP, Verpoorte R, Williamson EM, Duez P.
J Ethnopharmacol. 2012; 140: 469-475
http://www.sciencedirect.com/science/article/pii/S0378874112000517
4. The formation of daodi medicinal materials.
Zhao Z, Guo P, Brand E.
J Ethnopharmacol. 2012; 140: 476-481
http://www.sciencedirect.com/science/article/pii/S037887411200061X
5. The potential of metabolic fingerprinting as a tool for the modernisation of TCM preparations.
Sheridan H, Krenn L, Jiang R, Sutherland I, Ignatova S, Marmann A, Liang X, Sendker J.
J Ethnopharmacol. 2012; 140: 482-491
http://www.sciencedirect.com/science/article/pii/S0378874112000633
6. Review of current and “omics” methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms.
Ouedraogo M, Baudoux T, Stévigny C, Nortier J, Colet JM, Efferth T, Qu F, Zhou J, Chan K, Shaw D, Pelkonen O, Duez P.
J Ethnopharmacol. 2012; 140: 492-512
http://www.sciencedirect.com/science/article/pii/S0378874112001146
7. Pharmacovigilance of herbal medicine.
Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C.
J Ethnopharmacol. 2012; 140: 513-518
http://www.sciencedirect.com/science/article/pii/S0378874112000645
8. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective.
Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, Chan K, Shaw D, Duez P.
J Ethnopharmacol. 2012; 140: 519-525
http://www.sciencedirect.com/science/article/pii/S0378874112001122
9. In-silico studies in Chinese herbal medicines’ research: Evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date.
Barlow DJ, Buriani A, Ehrman T, Bosisio E, Eberini I, Hylands PJ.
J Ethnopharmacol. 2012; 140: 526-534
http://www.sciencedirect.com/science/article/pii/S0378874112000542
10. Omic techniques in systems biology approaches to traditional Chinese medicine research: Present and future.
Buriani A, Garcia-Bermejo ML, Bosisio E, Xu Q, Li H, Dong X, Simmonds MS, Carrara M, Tejedor N, Lucio-Cazaña J, Hylands PJ.
J Ethnopharmacol. 2012; 140: 535-544
http://www.sciencedirect.com/science/article/pii/S0378874112000682
11. MEDLINE-based assessment of animal studies on Chinese herbal medicine.
Tejedor Garcia N, Garcia Bermejo L, Fernandez Martinez AB, Olmos Centenera G, Kumari R, Xu Q, Cheng X, Watson S, Lucio Cazaña FJ.
J Ethnopharmacol. 2012; 140: 545-549
http://www.sciencedirect.com/science/article/pii/S037887411200089X
12. Guidelines for randomised controlled trials investigating Chinese herbal medicine.
Flower A, Witt C, Liu JP, Ulrich-Merzenich G, Yu H, Lewith G.
J Ethnopharmacol. 2012; 140: 550-554
http://www.sciencedirect.com/science/article/pii/S0378874111008956
13. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: A systematic review of randomized clinical trials.
Luo H, Li Q, Flower A, Lewith G, Liu J.
J Ethnopharmacol. 2012; 140: 555-567
http://www.sciencedirect.com/science/article/pii/S037887411200044X
14. Future development of global regulations of Chinese herbal products.
Fan TP, Deal G, Koo HL, Rees D, Sun H, Chen S, Dou JH, Makarov VG, Pozharitskaya ON, Shikov AN, Kim YS, Huang YT, Chang YS, Jia W, Dias A, Wong VC, Chan K.
J Ethnopharmacol. 2012; 140: 568-586
http://www.sciencedirect.com/science/article/pii/S0378874112001134
15. Omics and its potential impact on R&D and regulation of complex herbal products.
Pelkonen O, Pasanen M, Lindon JC, Chan K, Zhao L, Deal G, Xu Q, Fan TP.
J Ethnopharmacol. 2012; 140: 587-593
http://www.sciencedirect.com/science/article/pii/S0378874112000487
16. A review of Omics research in acupuncture: The relevance and future prospects for understanding the nature of meridians and acupoints.
Jia J, Yu Y, Deng JH, Robinson N, Bovey M, Cui YH, Liu HR, Ding W, Wu HG, Wang XM.
J Ethnopharmacol. 2012; 140: 594-603
http://www.sciencedirect.com/science/article/pii/S0378874112000475
17. Exploring practice characteristics and research priorities of practitioners of traditional acupuncture in China and the EU-A survey.
Robinson N, Lorenc A, Ding W, Jia J, Bovey M, Wang XM.
J Ethnopharmacol. 2012; 140: 604-613
http://www.sciencedirect.com/science/article/pii/S0378874112000657
18. Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy.
Liu SH, Cheng YC.
J Ethnopharmacol. 2012; 140: 614-623
http://www.sciencedirect.com/science/article/pii/S0378874112000608
19. Value chains of herbal medicines-Research needs and key challenges in the context of ethnopharmacology.
Booker A, Johnston D, Heinrich M.
J Ethnopharmacol. 2012; 140: 624-633
http://www.sciencedirect.com/science/article/pii/S0378874112000529
20. Syndrome differentiation in modern research of traditional Chinese medicine.
Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, Chan K.
J Ethnopharmacol. 2012; 140: 634-642
http://www.sciencedirect.com/science/article/pii/S0378874112000463
